(Q71523193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

review article

1 reference

title

Nonsteroidal anti-inflammatory drug gastropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

Laine L

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 July 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

Gastrointestinal endoscopy clinics of North America

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

489-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

Aspirin-induced ultrastructural changes in human gastric mucosa: correlation with potential difference

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

A double-blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Nonsteroidal antiinflammatory drugs--differences and similarities

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Reflux gastritis: distinct histopathological entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Gastric adaptation occurs with aspirin administration in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Ulcer complications and nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Histological study of the effects of three anti-inflammatory preparations on the gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Acute gastric mucosal injury during continuous or interrupted aspirin ingestion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Gastritis in patients on non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Salicylsalicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin. An endoscopic comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

Chronic gastritis--a pathogenetic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2818%2930351-9

7 January 2021

10.1016/S1052-5157(18)30351-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8803564%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference